Why Verrica Pharmaceuticals Stock Is Trading Lower Today

Loading...
Loading...

Verrica Pharmaceuticals VRCA shares are trading lower on Tuesday.

The company received a letter from the FDA regarding its VP-102 NDA indicating there are deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.

Verrica Pharmaceuticals is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Verrica Pharmaceuticals shares were trading down 25.8% at $10.44 at the time of publication Tuesday. The stock has a 52-week high of $18.67 and a 52-week low of $6.79.

Posted In: NewsMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...